Watch Demo

Belgium Cardiovascular Drug Industry Outlook 2022 - 2026

See how Belgium Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Belgian beta blocking medicine sales are set to hit $71.56 million by 2026. This figure is a slight decrease from the $86.13 million reported in 2021. On average, the market has fallen by 2.8% year on year since 2007. South Korea overtook Belgium in 2021 and came in at number one with sales of $86.13 million. Italy, Canada and Australia took second, third and fourth place respectively.

Marketing Banner

Belgium Cardiovascular Drug Market Data and Forecasts

How much will Belgium Cardiovascular Drug Market grow to 2026?

Forecast: Beta Blocking Medicine Sales in Belgium
Forecast: Diuretic Medicine Sales in Belgium
Forecast: Antihypertensive Medicine Sales in Belgium
Forecast: Antiarrhythmic Medicine Sales in Belgium
Forecast: Diuretic Medicine Sales in Belgium
More in Cardiovascular Drug Industry for 2028